Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
JACC Cardiovasc Interv. 2018 Oct 22;11(20):2099-2109. doi: 10.1016/j.jcin.2018.07.031.
The study sought to investigate the prognostic implications of relative increase of fractional flow reserve (FFR) with PCI in combination with post-percutaneous coronary intervention (PCI) FFR.
FFR, measured after PCI has been shown to possess prognostic implications. The relative increase of FFR with PCI can be determined by the interaction of baseline disease pattern, adequacy of PCI, and residual disease burden in a target vessel. However, the role of relative increase of FFR with PCI has not yet been evaluated.
A total of 621 patients who underwent PCI using second-generation drug-eluting stents based on low pre-PCI FFR (≤0.80) and available post-PCI FFR were analyzed. The relative increase of FFR was calculated by %FFR increase with PCI ([post-PCI FFR - pre-PCI FFR]/pre-PCI FFR × 100). Patients were divided according to the optimal cutoff values of post-PCI FFR (<0.84) and %FFR increase (≤15%). The primary outcome was target vessel failure (TVF) (a composite of cardiac death, target vessel-related myocardial infarction, and clinically driven target vessel revascularization) at 2 years.
Among the total population, 66.0% showed high post-PCI FFR (≥0.84) and 69.2% showed high %FFR increase (>15%). Patients with low post-PCI FFR showed a higher risk of 2-year TVF than did those with high post-PCI FFR (9.1% vs. 2.6%; hazard ratio [HR]: 3.367; 95% confidence interval [CI]: 1.412 to 8.025; p = 0.006). Patients with low %FFR increase also showed a higher risk of 2-year TVF compared with those with high %FFR increase (9.2% vs. 3.0%; HR: 3.613; 95% CI: 1.543 to 8.458; p = 0.003). Among the high post-PCI FFR group, there were no significant differences in clinical outcomes according to %FFR increase. Conversely, among the low post-PCI FFR group, those with low %FFR increase showed a significantly higher risk of TVF than did those with high %FFR increase (14.3% vs. 4.1%; HR: 4.334; 95% CI: 1.205 to 15.594; p = 0.025). Percent FFR increase significantly increased discriminant and reclassification ability for the occurrence of TVF when added to a model with clinical risk factors and post-PCI FFR (C-index 0.783 vs. 0.734; relative integrated discrimination improvement 0.702; p = 0.009; category-free net reclassification index 0.479; p = 0.031).
Percent FFR increase with PCI showed similar prognostic implications with post-PCI FFR. Adding the relative increase of FFR to post-PCI FFR would enable better discrimination of high-risk patients after stent implantation. (Influence of FFR on the Clinical Outcome After Percutaneous Coronary Intervention [PERSPECTIVE]; NCT01873560).
本研究旨在探讨经皮冠状动脉介入治疗(PCI)后血流储备分数(FFR)相对增加与预后的关系。
研究表明,PCI 后测量的 FFR 具有预后意义。PCI 后 FFR 的相对增加可以通过基线病变模式、PCI 的充分性以及靶血管内残余病变负担的相互作用来确定。然而,PCI 后 FFR 相对增加的作用尚未得到评估。
共分析了 621 例接受基于低预 PCI FFR(≤0.80)的第二代药物洗脱支架 PCI 的患者,并且有可用的 PCI 后 FFR。通过 %FFR 增加([PCI 后 FFR-预 PCI FFR]/预 PCI FFR×100)计算 FFR 的相对增加。根据最佳的 PCI 后 FFR(<0.84)和 %FFR 增加(≤15%)截断值将患者分为两组。主要终点是 2 年时的靶血管失败(TVF)(包括心脏死亡、靶血管相关心肌梗死和临床驱动的靶血管血运重建的复合终点)。
在总人群中,66.0%的患者表现出高 PCI 后 FFR(≥0.84),69.2%的患者表现出高 %FFR 增加(>15%)。低 PCI 后 FFR 的患者比高 PCI 后 FFR 的患者 2 年 TVF 风险更高(9.1% vs. 2.6%;风险比[HR]:3.367;95%置信区间[CI]:1.412 至 8.025;p=0.006)。低 %FFR 增加的患者比高 %FFR 增加的患者 2 年 TVF 风险更高(9.2% vs. 3.0%;HR:3.613;95%CI:1.543 至 8.458;p=0.003)。在高 PCI 后 FFR 组中,根据 %FFR 增加,临床结局无显著差异。相反,在低 PCI 后 FFR 组中,低 %FFR 增加的患者 TVF 风险明显高于高 %FFR 增加的患者(14.3% vs. 4.1%;HR:4.334;95%CI:1.205 至 15.594;p=0.025)。当将 %FFR 增加与临床危险因素和 PCI 后 FFR 相结合纳入模型时,%FFR 增加显著提高了 TVF 发生的判别和再分类能力(C 指数 0.783 比 0.734;相对综合判别改善 0.702;p=0.009;无分类净再分类指数 0.479;p=0.031)。
PCI 后 FFR 相对增加与 PCI 后 FFR 具有相似的预后意义。将 FFR 的相对增加添加到 PCI 后 FFR 中,可以更好地区分支架植入后的高危患者。(经皮冠状动脉介入治疗后 FFR 的影响[透视];NCT01873560)。